Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans
We are issuing this notice to help drug manufacturers and sponsors when preparing the Canadian-specific considerations and elements in the risk management plans (RMPs) for certain drug products. This notice describes what is required for certain drug products.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2024-04-04
Data overview
- Formats
- HTML
- File languages
- English, French